Literature DB >> 18848138

What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy?

Deepak L Bhatt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18848138     DOI： 10.1016/j.jacc.2008.06.027

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  9 in total

Review 1.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  The evolution of antiplatelet therapy in cardiovascular disease.

Authors:  Omair Yousuf; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2011-07-12       Impact factor: 32.419

3.  State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

Authors:  Dharam J Kumbhani; Steven P Marso; Carlos A Alvarez; Darren K McGuire
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-01

Review 4.  Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence.

Authors:  Kumaran Kolandaivelu; Deepak L Bhatt
Journal:  Nat Rev Cardiol       Date:  2010-06-01       Impact factor: 32.419

5.  Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.

Authors:  Anna Grodzinsky; Suzanne V Arnold; Tracy Y Wang; Praneet Sharma; Kensey Gosch; Philip G Jones; Deepak L Bhatt; Philippe Gabriel Steg; Darren K McGuire; David J Cohen; John A Spertus; Adnan K Chhatriwalla; Marcus Lind; Garth Graham; Mikhail Kosiborod
Journal:  Am Heart J       Date:  2016-10-02       Impact factor: 4.749

Review 6.  Proton pump inhibitors and potential interactions with clopidogrel: an update.

Authors:  Lauren B Gerson
Journal:  Curr Gastroenterol Rep       Date:  2013-06

7.  13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Tochi M Okwuosa; Oana Klein; Cheeling Chan; Nancy Swords Jenny; Pamela Schreiner; David Green; Kiang Liu
Journal:  Atherosclerosis       Date:  2012-10-25       Impact factor: 5.162

Review 8.  Role of von Willebrand factor in venous thromboembolic disease.

Authors:  Alison Michels; David Lillicrap; Michael Yacob
Journal:  JVS Vasc Sci       Date:  2021-10-07

9.  Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome.

Authors:  Girish N Viswanathan; Sally M Marshall; Karthik Balasubramaniam; Juan J Badimon; Azfar G Zaman
Journal:  Thromb Res       Date:  2014-02-01       Impact factor: 3.944
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.